Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model

The retraction notice states that T Arichi's actions 'were taken without the knowledge of the other authors.'; There is a Findings of scientific misconduct for this article (T Arichi): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259639/.;